JONATHAN G DRACHMAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JONATHAN G DRACHMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JONATHAN G DRACHMAN. JONATHAN G DRACHMAN is CMO & EVP, R & D in SEATTLE GENETICS INC /WA ($SGEN) and See Remarks in SEATTLE GENETICS INC /WA ($SGEN) and President and CEO in Neoleukin Therapeutics, Inc. ($AQXP) and See Remarks in Neoleukin Therapeutics, Inc. ($AQXP) and Director in Calithera Biosciences, Inc. ($CALA) and Director in Harpoon Therapeutics, Inc. ($HARP).
Latest Insider Trading Transactions of JONATHAN G DRACHMAN
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CALA, HARP, NLTX, SGEN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 07 2021 | HARP | Harpoon Therapeuti ... | DRACHMAN JONATHAN G | Director | Option Exercise | A | 22.50 | 10,167 | 228,758 | 10,167 | |
| Aug 12 2020 | NLTX | Neoleukin Therapeu ... | DRACHMAN JONATHAN G | President and CEO | Option Exercise | A | 12.00 | 420,000 | 5,040,000 | 420,000 | |
| Jun 11 2020 | CALA | Calithera Bioscien ... | DRACHMAN JONATHAN G | Director | Option Exercise | A | 5.25 | 20,000 | 105,000 | 20,000 | |
| Jun 01 2020 | HARP | Harpoon Therapeuti ... | DRACHMAN JONATHAN G | Director | Option Exercise | A | 20.59 | 2,880 | 59,299 | 2,880 | |
| Jun 01 2020 | HARP | Harpoon Therapeuti ... | DRACHMAN JONATHAN G | Director | Option Exercise | A | 20.59 | 10,167 | 209,339 | 10,167 | |
| Dec 20 2019 | AQXP | Neoleukin Therapeu ... | DRACHMAN JONATHAN G | President and CEO | Buy | P | 8.40 | 119,047 | 999,995 | 2,198,686 | 2.1 M to 2.2 M (+5.72 %) |
| Dec 20 2019 | AQXP | Neoleukin Therapeu ... | DRACHMAN JONATHAN G | President and CEO | Buy | C | 0.00 | 1,261,600 | 0 | 2,079,639 | 818 K to 2.1 M (+154.22 %) |
| Dec 20 2019 | AQXP | Neoleukin Therapeu ... | DRACHMAN JONATHAN G | President and CEO | Sell | C | 0.00 | 12,616 | 0 | 0 | 12.6 K to 0 (-100.00 %) |
| Sep 11 2019 | AQXP | Neoleukin Therapeu ... | DRACHMAN JONATHAN G | See Remarks | Buy | P | 3.30 | 136,436 | 449,898 | 584,428 | 448 K to 584.4 K (+30.46 %) |
| Sep 11 2019 | AQXP | Neoleukin Therapeu ... | DRACHMAN JONATHAN G | See Remarks | Buy | P | 3.08 | 36,742 | 113,290 | 447,992 | 411.3 K to 448 K (+8.93 %) |
| Sep 11 2019 | AQXP | Neoleukin Therapeu ... | DRACHMAN JONATHAN G | See Remarks | Buy | P | 2.85 | 76,822 | 218,559 | 411,250 | 334.4 K to 411.3 K (+22.97 %) |
| Sep 04 2019 | AQXP | Neoleukin Therapeu ... | DRACHMAN JONATHAN G | See Remarks | Option Exercise | A | 2.80 | 1,650,000 | 4,620,000 | 1,650,000 | |
| Aug 12 2019 | AQXP | Neoleukin Therapeu ... | DRACHMAN JONATHAN G | President and CEO | Grant | A | 0.00 | 7,428 | 0 | 7,428 | 0 to 7.4 K |
| Aug 12 2019 | AQXP | Neoleukin Therapeu ... | DRACHMAN JONATHAN G | President and CEO | Grant | A | 0.00 | 334,428 | 0 | 334,428 | 0 to 334.4 K |
| Jun 05 2019 | HARP | Harpoon Therapeuti ... | DRACHMAN JONATHAN G | Director | Option Exercise | A | 11.84 | 10,167 | 120,377 | 10,167 | |
| Jun 03 2019 | CALA | Calithera Bioscien ... | DRACHMAN JONATHAN G | Director | Option Exercise | A | 5.42 | 11,000 | 59,620 | 11,000 | |
| Mar 29 2019 | HARP | Harpoon Therapeuti ... | DRACHMAN JONATHAN G | Director | Option Exercise | A | 14.00 | 4,266 | 59,724 | 4,266 | |
| Jun 04 2018 | CALA | Calithera Bioscien ... | DRACHMAN JONATHAN G | Director | Option Exercise | A | 5.15 | 11,000 | 56,650 | 11,000 | |
| Mar 22 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | M | 12.00 | 13,740 | 164,880 | 45,000 | |
| Mar 22 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | M | 10.61 | 7,000 | 74,270 | 0 | |
| Mar 22 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | M | 26.10 | 3,831 | 99,989 | 0 | |
| Mar 22 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | M | 15.46 | 6,468 | 99,995 | 0 | |
| Mar 22 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Buy | M | 10.61 | 7,000 | 74,270 | 201,973 | 195 K to 202 K (+3.59 %) |
| Mar 22 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Buy | M | 12.00 | 13,740 | 164,880 | 194,973 | 181.2 K to 195 K (+7.58 %) |
| Mar 22 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Buy | M | 15.46 | 6,468 | 99,995 | 181,233 | 174.8 K to 181.2 K (+3.70 %) |
| Mar 22 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Buy | M | 26.10 | 3,831 | 99,989 | 174,765 | 170.9 K to 174.8 K (+2.24 %) |
| Mar 22 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | See Remarks | Option Exercise | A | 34.20 | 10,526 | 359,989 | 10,526 | |
| Mar 07 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | M | 8.96 | 3,257 | 29,183 | 0 | |
| Mar 07 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | M | 8.96 | 7,200 | 64,512 | 3,257 | |
| Mar 07 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Sell | S | 53.12 | 3,257 | 173,012 | 170,934 | 174.2 K to 170.9 K (-1.87 %) |
| Mar 07 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Buy | M | 8.96 | 3,257 | 29,183 | 174,191 | 170.9 K to 174.2 K (+1.91 %) |
| Mar 07 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Sell | S | 52.70 | 7,200 | 379,440 | 170,934 | 178.1 K to 170.9 K (-4.04 %) |
| Mar 07 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Buy | M | 8.96 | 7,200 | 64,512 | 178,134 | 170.9 K to 178.1 K (+4.21 %) |
| Jan 16 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | M | 10.61 | 13,156 | 139,585 | 7,000 | |
| Jan 16 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | M | 12.00 | 6,260 | 75,120 | 0 | |
| Jan 16 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Buy | M | 10.61 | 13,156 | 139,585 | 170,934 | 157.8 K to 170.9 K (+8.34 %) |
| Jan 16 2018 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Buy | M | 12.00 | 6,260 | 75,120 | 157,778 | 151.5 K to 157.8 K (+4.13 %) |
| Oct 10 2017 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | M | 12.16 | 8,223 | 99,992 | 0 | |
| Oct 10 2017 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | M | 11.09 | 7,249 | 80,391 | 0 | |
| Oct 10 2017 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | M | 10.61 | 2,344 | 24,870 | 0 | |
| Oct 10 2017 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Buy | M | 12.16 | 8,223 | 99,992 | 151,518 | 143.3 K to 151.5 K (+5.74 %) |
| Oct 10 2017 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Buy | M | 10.61 | 2,344 | 24,870 | 143,295 | 141 K to 143.3 K (+1.66 %) |
| Oct 10 2017 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Buy | M | 11.09 | 7,249 | 80,391 | 140,951 | 133.7 K to 141 K (+5.42 %) |
| Aug 30 2017 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Sell | S | 47.89 | 8,502 | 407,199 | 133,702 | 142.2 K to 133.7 K (-5.98 %) |
| Aug 25 2017 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | M | 10.29 | 10,000 | 102,900 | 0 | |
| Aug 25 2017 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Sell | S | 47.54 | 10,000 | 475,414 | 142,204 | 152.2 K to 142.2 K (-6.57 %) |
| Aug 25 2017 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Buy | M | 10.29 | 10,000 | 102,900 | 152,204 | 142.2 K to 152.2 K (+7.03 %) |
| Aug 18 2017 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | A | 46.37 | 65,344 | 3,030,001 | 65,344 | |
| Aug 18 2017 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | A | 46.37 | 2,156 | 99,974 | 2,156 | |
| Aug 18 2017 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Grant | A | 0.00 | 27,000 | 0 | 142,204 | 115.2 K to 142.2 K (+23.44 %) |
| Jul 31 2017 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | M | 10.29 | 10,000 | 102,900 | 10,000 | |
| Jul 31 2017 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Sell | S | 54.54 | 10,000 | 545,361 | 115,204 | 125.2 K to 115.2 K (-7.99 %) |
| Jul 31 2017 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Buy | M | 10.29 | 10,000 | 102,900 | 125,204 | 115.2 K to 125.2 K (+8.68 %) |
| Jun 26 2017 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | M | 10.29 | 10,000 | 102,900 | 20,000 | |
| Jun 26 2017 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Sell | S | 64.58 | 100 | 6,458 | 115,204 | 115.3 K to 115.2 K (-0.09 %) |
| Jun 26 2017 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Sell | S | 64.00 | 9,900 | 633,600 | 115,304 | 125.2 K to 115.3 K (-7.91 %) |
| Jun 26 2017 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Buy | M | 10.29 | 10,000 | 102,900 | 125,204 | 115.2 K to 125.2 K (+8.68 %) |
| Jun 13 2017 | CALA | Calithera Bioscien ... | DRACHMAN JONATHAN G | Director | Option Exercise | A | 14.20 | 11,000 | 156,200 | 11,000 | |
| Jan 26 2017 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | M | 10.29 | 5,000 | 51,450 | 0 | |
| Jan 26 2017 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Buy | M | 10.29 | 5,000 | 51,450 | 114,837 | 109.8 K to 114.8 K (+4.55 %) |
| Nov 14 2016 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | M | 11.09 | 7,751 | 85,959 | 40,000 | |
| Nov 14 2016 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Sell | S | 66.75 | 7,751 | 517,379 | 109,837 | 117.6 K to 109.8 K (-6.59 %) |
| Nov 14 2016 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Buy | M | 11.09 | 7,751 | 85,959 | 117,588 | 109.8 K to 117.6 K (+7.06 %) |
| Nov 03 2016 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Sell | S | 51.74 | 3,418 | 176,847 | 109,837 | 113.3 K to 109.8 K (-3.02 %) |
| Sep 23 2016 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | M | 10.29 | 2,249 | 23,142 | 30,000 | |
| Sep 23 2016 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Sell | S | 56.75 | 2,249 | 127,631 | 113,255 | 115.5 K to 113.3 K (-1.95 %) |
| Sep 23 2016 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Buy | M | 10.29 | 2,249 | 23,142 | 115,504 | 113.3 K to 115.5 K (+1.99 %) |
| Aug 30 2016 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | A | 45.30 | 70,293 | 3,184,273 | 70,293 | |
| Aug 30 2016 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | A | 45.30 | 2,207 | 99,977 | 2,207 | |
| Aug 30 2016 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Grant | A | 0.00 | 29,000 | 0 | 113,255 | 84.3 K to 113.3 K (+34.42 %) |
| Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Sell | S | 46.59 | 3,991 | 185,943 | 84,255 | 88.2 K to 84.3 K (-4.52 %) |
| Jun 16 2016 | CALA | Calithera Bioscien ... | DRACHMAN JONATHAN G | Director | Option Exercise | A | 4.76 | 11,000 | 52,360 | 11,000 | |
| Jun 06 2016 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | M | 10.29 | 5,000 | 51,450 | 5,000 | |
| Jun 06 2016 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Buy | M | 10.29 | 5,000 | 51,450 | 88,246 | 83.2 K to 88.2 K (+6.01 %) |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | A | 39.15 | 47,446 | 1,857,511 | 47,446 | |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | A | 39.15 | 2,554 | 99,989 | 2,554 | |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Grant | A | 0.00 | 20,000 | 0 | 82,724 | 62.7 K to 82.7 K (+31.89 %) |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Sell | S | 42.02 | 4,462 | 187,513 | 62,724 | 67.2 K to 62.7 K (-6.64 %) |
| Jun 11 2015 | CALA | Calithera Bioscien ... | DRACHMAN JONATHAN G | Director | Option Exercise | A | 7.99 | 11,000 | 87,890 | 39,355 | |
| Aug 27 2014 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | A | 44.09 | 47,732 | 2,104,504 | 47,732 | |
| Aug 27 2014 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | A | 44.09 | 2,268 | 99,996 | 2,268 | |
| Aug 27 2014 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Grant | A | 0.00 | 20,000 | 0 | 66,481 | 46.5 K to 66.5 K (+43.03 %) |
| Aug 27 2014 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Sell | S | 43.55 | 2,772 | 120,718 | 46,481 | 49.3 K to 46.5 K (-5.63 %) |
| Feb 24 2014 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Sell | S | 53.25 | 1,241 | 66,083 | 48,670 | 49.9 K to 48.7 K (-2.49 %) |
| Jan 21 2014 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Sell | S | 45.75 | 1,201 | 54,946 | 49,911 | 51.1 K to 49.9 K (-2.35 %) |
| Nov 14 2013 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Grant | A | 0.00 | 8,100 | 0 | 51,112 | 43 K to 51.1 K (+18.83 %) |
Page: 1